The Latest in Ovarian Cancer Treatment

On September 17th Dana-Farber/Brigham and Women’s Cancer Center gynecologic oncology expert, Ursula A. Matulonis, MD, presented an overview of the latest in ovarian cancer treatment and answered questions during a live Web chat.

matulonis Dr. Matulonis is the medical director of the Gynecologic Oncology Program at Dana-Farber/Brigham and Women’s Cancer Center, and one of the leaders of its Susan F. Smith Center for Women’s Cancers. Dr. Matulonis’ research focuses on new treatments for gynecologic malignancies, with a particular emphasis on ovarian cancer. She is the principal investigator for several ovarian cancer clinical trials and serves on the National Comprehensive Cancer Network’s ovarian cancer committee, which sets patient care guidelines for physicians across the country. Dr. Matulonis has received several awards for her dedication and excellence in the field. Click here for Dr. Matulonis’ bio.

Each year in the United States, more than 22,000 women will be diagnosed with ovarian cancer. Understanding treatment options, the role of different doctors specializing in the treatment of ovarian cancer, and how and when to access new and innovative cancer treatment options available through clinical trials is essential in order to achieve the best outcome from cancer treatment.

You can view the Web Chat above or click here.  Please note, we appreciate all of the questions that were submitted for Dr. Matulonis. Thank you for your participation.

The Web Chat with the Expert series is not intended to be a substitute for advice from a healthcare professional, diagnosis, or treatment. Speak to your healthcare provider about any questions you may have regarding your health.